Atlas Trials

a Study in Subjects With Otoferlin Mutation-related Hearing Loss Using RNA Base-eDiting Therapy(SOUND)

Clinical trial NCT06025032 · WITHDRAWN

Trial details

NCT number
NCT06025032
Sponsor
HuidaGene Therapeutics Co., Ltd.
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Congenital Hearing Loss
Start date
2023-03-30
Primary completion
2025-04-08
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.